• Reported GAAP EPS of $4.10 up 1071.43% YoY • Reported revenue of $358M up 19.73% YoY • Indivior reaffirmed full-year 2026 financial guidance, projecting total net revenue between $1.13B and $1.2B, and Adjusted EBITDA between $535M and $575M. Indivior expects SUBLOCADE dispense unit growth in the mid-teens.
Bullish
Indivior demonstrated strong SUBLOCADE revenue growth, with Q4 net revenue up 30% year-over-year, and achieved significant profitability improvements. The company also advanced strategic initiatives, including a $400M share repurchase program and U.S. redomiciliation.
Bearish
Indivior experienced a significant cash reduction due to a $295M DOJ settlement prepayment. The company also saw increased Q4 GAAP operating expenses and discontinued support for OPVEE and PERSERIS, indicating portfolio challenges.